C., Creanor, S., Davies, M
For additional background on telehealth GLP-1 programs and how they work, see our comprehensive consumer guide to Elevate Health's platform structure
Gates and discussing her treatment options, she felt confident about conquering her pain
These label expansions unlocked new pathways for coverage, and by early 2025 the proportion of Medicare patients with diabetes or obesity initiating GLP-1 therapy rose sharply
Understanding why this occurs and implementing proactive strategies helps patients maintain bowel regularity while benefiting from tirzepatide's glycemic and weight management effects
Duopoly-like market The global pharmaceutical weight-loss market has effectively consolidated into a duopoly, led by Novo Nordisk and Eli Lilly